Kopczynski Casey C. 4
4 · AERIE PHARMACEUTICALS INC · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Kopczynski Casey C.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-11-11$13.01/sh−22,695$295,210→ 196,114 total - Sale
Common Stock
2020-11-10$13.00/sh−7,305$94,965→ 218,809 total
Footnotes (2)
- [F1]Following the sales reported on this Form 4, the reporting person's Rule 10b5-1 plan dated May 15, 2020 is completed.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.03, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.